共 76 条
[1]
Hajarizadeh B(2017)Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment J Gastroenterol Hepatol 32 229-236
[2]
Grebely J(2018)Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia Harm Reduct J 15 1-8
[3]
McManus H(2018)Elimination of hepatitis C virus in Australia: laying the foundation Infect Dis Clin 32 269-279
[4]
Estes C(2013)Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection Clin Infect Dis. 57 S75-9
[5]
Razavi H(2015)Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia Int J Drug Policy 26 992-998
[6]
Gray RT(2019)Making sense of ‘side effects’: counterpublic health in the era of direct-acting antivirals Int J Drug Policy 72 77-83
[7]
Alavi M(2017)Perceived benefits of the hepatitis C peer educators: a qualitative investigation Harm Reduct J 14 1-7
[8]
Amin J(2007)Integrating HCV services for drug users: a model to improve engagement and outcomes Int J Drug Policy 18 406-410
[9]
McGregor S(2013)Understanding barriers to hepatitis C virus care and stigmatization from a social perspective Clin Infect Dis 57 S51-S55
[10]
Sievert W(2018)Uptake of direct-acting antiviral treatment for chronic hepatitis C in Australia J Viral Hepatitis 25 640-648